NxStage Announces CE Mark Approval for New High Flow Capabilities with System One (via PR Newswire)Latest Pipeline Advancement Expands Therapeutic Flexibility of System One Download image LAWRENCE, Mass., Feb. 21, 2013 /PRNewswire/ — NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced CE Mark approval for new high flow capabilities with…
published: February 22, 2013 in: Approval/Clearance, Technology